TX DX Pipeline

The projects below are indicative of the scope and progress of projects that Sengenics has been involved in with various collaborators. In the past 12 months, Sengenics has partnered with 27 new organizations ranging from top pharmaceutical companies to academic institutions spanning the United States, Europe and Asia. If you are thinking of leveraging Immunome for research areas that you are particularly interested in, please feel free to contact us.